Cantor picks 14 undervalued biotech stocks worth a second look
Seeking Alpha News (Sun, 12-May 11:00 AM ET)
Piper Sandler Sticks to Their Buy Rating for Prothena (PRTA)
TipRanks (Fri, 10-May 8:05 AM ET)
Buy Rating Affirmed for Prothena Amid Strong Pipeline and Financial Health
TipRanks (Fri, 10-May 1:30 AM ET)
Buy Rating Affirmed: Prothena’s Prasinezumab Shows Promise in Slowing Parkinson’s Progression
TipRanks (Thu, 9-May 8:25 AM ET)
RBC Capital Sticks to Their Hold Rating for Prothena (PRTA)
TipRanks (Thu, 9-May 6:53 AM ET)
Analysts Are Bullish on These Healthcare Stocks: Paragon 28 (FNA), Prothena (PRTA)
TipRanks (Thu, 9-May 12:50 AM ET)
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
Business Wire (Wed, 8-May 4:05 PM ET)
Prothena to Report First Quarter 2024 Financial Results on May 8
Business Wire (Wed, 1-May 4:05 PM ET)
Business Wire (Mon, 15-Apr 4:05 PM ET)
Prothena to Participate in Upcoming Healthcare Conferences
Business Wire (Tue, 5-Mar 4:05 PM ET)
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
Prothena PLC - trades on the NASDAQ stock market under the symbol PRTA.
As of May 14, 2024, PRTA stock price declined to $20.68 with 478,705 million shares trading.
PRTA has a beta of 1.10, meaning it tends to be more sensitive to market movements. PRTA has a correlation of 0.07 to the broad based SPY ETF.
PRTA has a market cap of $1.11 billion. This is considered a Small Cap stock.
Last quarter Prothena PLC - reported $50,000 in Revenue and -$1.34 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.14.
In the last 3 years, PRTA stock traded as high as $79.75 and as low as $19.65.
The top ETF exchange traded funds that PRTA belongs to (by Net Assets): XBI, IWM, VXF, IWO, IBB.
PRTA has underperformed the market in the last year with a price return of -71.6% while the SPY ETF gained +28.8%. PRTA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.9% and -2.4%, respectively, while the SPY returned +6.2% and +2.6%, respectively.
PRTA support price is $20.03 and resistance is $21.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRTA stock will trade within this expected range on the day.